1. Home
  2. CRVS vs TMP Comparison

CRVS vs TMP Comparison

Compare CRVS & TMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$18.15

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Tompkins Financial Corporation

TMP

Tompkins Financial Corporation

HOLD

Current Price

$83.86

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
TMP
Founded
2014
1836
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
CRVS
TMP
Price
$18.15
$83.86
Analyst Decision
Strong Buy
Hold
Analyst Count
6
1
Target Price
$30.17
$74.00
AVG Volume (30 Days)
966.0K
47.1K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
3.22%
EPS Growth
48.04
126.16
EPS
N/A
11.24
Revenue
N/A
$75,742,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.94
P/E Ratio
N/A
$7.40
Revenue Growth
N/A
N/A
52 Week Low
$3.17
$58.12
52 Week High
$26.95
$86.95

Technical Indicators

Market Signals
Indicator
CRVS
TMP
Relative Strength Index (RSI) 64.18 58.75
Support Level $16.15 $72.14
Resistance Level $18.73 $86.66
Average True Range (ATR) 1.02 1.73
MACD 0.39 0.08
Stochastic Oscillator 70.07 61.77

Price Performance

Historical Comparison
CRVS
TMP

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About TMP Tompkins Financial Corporation

Tompkins Financial Corp is a Financial Holding Company. The company manages its operations through two business segments, consisting of banking and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates the majority of its revenue from the Banking segment.

Share on Social Networks: